A new Parkinson’s patient a day
And together we figured the way.
I said, “No treatment” and smiled,
“If the symptoms are mild,
“’Cause the progression it won’t delay.”
Synopsis: I’m a Family Practitioner from Sioux City, Iowa. In 2010 I danced back from the brink of burnout, and honoring a 1 year non-compete clause, traveled and worked in out-of-the-way places in Alaska, Nebraska, Iowa, and New Zealand. I followed 3 years Community Health Center work with further travel and adventures in temporary positions in Iowa, Pennsylvania, Nebraska, Canada, and Alaska. 2019 included hospitalist work in my home town and rural medicine in northern British Columbia. I did 10 months of telemedicine in my basement, followed by 5 months staffing a COVID-19 clinic in southeast Iowa. Since autumn, I’ve relaxed, exercised, done some telemedicine, and worked on administrative stuff for the next adventures. Since January 1, I worked a week in Iowa, attended a funeral in San Francisco, got Veterans Administration training in Pierre and Sturgis, South Dakota, and started work in 1 of 10 of the VA’s Community Based Outreach Clinics (CBOC) in South Dakota. Any opinions expressed are mine; any resemblance to VA opinion or policy is coincidental.
Up until this now this assignment has brought one new Parkinson’s patient daily. A few have the classic “pill-rolling” tremor, but all had lost music from their voices and animation from their faces. None had normal arm-swinging with walking, and all shuffled when making a 180-degree turn.
I told all of them (or their caregivers) that treatment (carbidopa-levodopa, tradename Sinemet) would not slow the progression of the disease but would help the symptoms. I emphasized that I never want the treatment to be worse than the disease; thus anyone not bothered by symptoms would probably be bothered by treatment. And the medication for mild symptoms can’t bring anything better than mild improvement.
This week I started hearing back from the first patients I diagnosed. One expressed delight at being able to resume household tasks. But one had significant side effects from the first pill and I advised against taking the second.
I heard from a tele-neurologist last afternoon about an unrelated patient, and I used the opportunity to get teaching on how to better treat my Parkinson’s patients. While Sinemet remains the mainstay of treatment, he gave me some pointers on how to initiate therapy.
I mentioned my distress at the amount of Parkinson’s I see in my Viet Nam veteran patients. The smiles of collegiality fell from our faces while we dwelt on the downstream horrors of Agent Orange.
Yet this week I didn’t see a single new Parkinson’s patient till to day in a veteran approaching 90, who had noticed no symptoms. “Nothing moves fast at your age,” I told him, “And I don’t foresee rapid disease progression. If you notice balance problems, stumbling, or falling, come back and we can discuss it. If it’s a problem in, say, 20 years, just remember that I noticed it first.”